THE STATE OF INNOVATION SPEAKER SERIES BRINGS LEADING RESEARCHERS AND INDUSTRY EXPERTS
TO ENGAGE WITH THE CAMPUS COMMUNITY ON CUTTING EDGE SCIENCE TOPICS.
2019-2020
Innovation in Engineering & Materials Science
Nancy Sottos, PhD
Donald B. Willett Professor of Engineering, University of Illinois at Urbana-Champaign
Speaker Series Seminar: Self-healing polymers – the long road from lab bench to commercialization”
Date: March 2, 2020
2019-2020: Innovation in Engineering & Materials Science
James Conley, PhD
Professor, Kellogg School of Management, Northwestern University
Education Series Seminar: Innovation Institutions and University-based Entrepreneurship. (February 6, 2020)
Cosponsored by the Office of the Vice President for Research
This talk highlighted how innovation institutions such as the intellectual property system is utilized to advance the productivity and appropriability of University based inventors, creators and brand advocates. Examples included UCDavis and Strawberries, Univ. of Minnesota (HoneyCrisp) and Washington State Univ.(Cosmic Crisp) in the apples game and Northwestern University in the Life Science space (Lyrica). Curricular efforts by the National Academy to encourage and enable innovation across the University was also presented.
Kenneth Gall, PhD
Professor in the Department of Mechanical Engineering and Materials Science; Associate Dean for Entrepreneurship in the Pratt School of Engineering, Duke University
Speaker Series Seminar: Translation of New Materials into Medical Implants (December 12, 2019)
Companies: MedShape, Vertera Spine
Robert O'Loughlin, JD
Counsel, Faegre Baker Daniels
Education Series Seminar: Considerations for Protecting Intellectual Property for Software, AI, & AR/VR Applications (December 4, 2019)
Robert O’Loughlin is a member of Faegre Baker Daniel’s intellectual property team. Bob approaches his practice with a focus on collaborating with clients to navigate intellectual property opportunities and risks in light of his clients’ objectives regarding innovation, commercialization and competition. His expertise includes computer software/engineering arts, electrical arts, and mechanical arts, with particular emphasis on Artificial Intelligence and subject matter eligibility under Section 101 and the Alice progeny of cases.
Education Series Panel: Government – University – Private Partnerships & Grand Challenges: Maximizing Impact in the 21st Century (November 7, 2019)
Programmatic approaches to translational research have been increasingly successful in attracting funding and providing early delivery of products to market. Whether these large collaborative efforts are in the guise of a Grand Challenge, a government-funded development effort, or a large research network, such efforts create impact by leveraging an established framework for driving change. TMI and CSU Ventures are collaborating to bring two key opinion leaders to the CSU campus, each of whom has a proven record in the realm of research development. Dr. Kevin Ward, Director of the Michigan Center for Integrative Research in Critical Care (MCIRCC) at the University of Michigan, and Dr. Kenneth Bertram, former Principal Assistant for Acquisition for the US Army Medical and Materiel Development Activity (USAMMDA) are both experienced in traditional research approaches as well as navigating issues related to integration of commercialization strategies, intellectual property, regulatory challenges, and market forces. Both have demonstrated success working with start-ups, industry partners, and government funding agencies to develop key life-saving innovations.
Kevin R. Ward, MD
Executive Director, Michigan Center for Integrative Research in Critical Care (MCIRCC), University of Michigan
Education Series Seminar: Fracking for Innovation
Michigan Center for Integrative Research in Critical Care (MCIRCC) website
Fast Forward Medical Innovation (FFMI) program
Kenneth Bertram, MD, PhD
Clinical Product Development Officer, Wake Forest Institute for Regenerative Medicine
Education Series Seminar: Civilian Trauma – Military Lessons
2018-2019: Regenerative Medicine
Shenda Baker, PhD
President & COO, Synedgen; Chief Science Officer, Synspira
April 23, 2019, Demo Day keynote: ”The Journey from Academia to Industry: A tale of therapeutic glycopolymers – bench to bedside and lessons learned”
Synedgen website
Synspira website
Presented in collaboration with Polsinelli law firm as part of the 2019 CSU Demo Day Innovation Symposium, and the Graduate School @ Colorado State University.
Anthony Atala, MD
Director of the Wake Forest Institute for Regenerative Medicine
February 20, 2019: “Translational Tissue & Organ Regeneration: Advances and Future Frontiers”
Presented in collaboration with the C. Wayne McIlwraith Translational Medicine Institute
Debra Mathews, PhD, MA
Assistant Director for Science Programs, Johns Hopkins Berman Institute of Bioethics;
January 31, 2019: “Ethics and Technological Convergence: Regenerative Medicine, Whole Genome Sequencing, and CRISPR”
Faculty website
Berman Institute website
Research Gate Profile
Presented in collaboration with the Graduate School, the Provost’s Ethics Colloquium, and the Research Integrity and Compliance Review Office.
Zoobiquity Colorado: Connecting Human and Animal Health through Regenerative Medicine
October 5 & 6, 2018: Zoobiquity Colorado: Connecting Human and Animal Health through Regenerative Medicine
College of Veterinary Medicine & Biomedical Sciences at Colorado State University,
University of Colorado School of Medicine
Highlighted: Regenerative Medicine, Aging, Limb Preservation, Childhood Cancers, Auto-Immune Disorders
Provided group transportation and free student registrations in collaboration with the Graduate School.
2017-2018: CRISPR
Stephen Badylak, DVM, PhD, MD
Professor, Department of Surgery; Deputy Director, McGowan Institute for Regenerative Medicine
April 13, 2018, Demo Day keynote: “Clinical Translation of Regenerative Medicine: Combining Basic Science with Patient Care”
Faculty/Laboratory website
McGowan Institute for Regenerative Medicine website
Vic Myer, PhD
Chief Technology Officer at Editas Medicine
February 21, 2018: “Perspectives from Industry: Harnessing the Power and Potential of CRISPR to Transform Medicine”
Presented in collaboration with the Office of the Vice President for Research, and the Graduate School.
Rodolphe Barrangou, PhD, MBA
Todd R. Klaenhammer Distinguished Professor, NC State University; Editor in Chief at The CRISPR Journal
November 7, 2017: “The CRISPR craze: exploiting genome editing machines in academia and industry”
Presented in collaboration with the Office of the Vice President for Research, and the Graduate School.
Tara Nealey
Intellectual Property Attorney for Polsinelli, PC
October 18, 2017: “Game of Unknowns: The CRISPR Patent Landscape”
Dan Voytas, PhD
Professor of Genetics, Cell Biology, & Development, University of Minnesota; Chief Science Officer, Calyxt
July 10, 2017: “Genome Editing in Rice: Development and Application”
Faculty website
Calyxt website
Presented in collaboration with the Jan Leach Laboratory at Colorado State University.